EUVIMEDEUVIMED entdecken
Vergleichsstudie

Steric Control of Competitive Versus Noncompetitive Lactoperoxidase Inhibition by Amide‐Linked Iridium(III) Complexes

Kevser Kübra Kırboğa iD, Fatma Sağır iD, Zeynep Köksal iD, Çiğdem Şahin

Archiv der Pharmazie · 2026

DOI: 10.1002/ardp.70346 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Kevser Kübra Kırboğa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Engineering, Department of Bioengineering, Bilecik Seyh Edebali University, Bilecik, Türkiye. Hauptthemen laut MEDLINE: Lactoperoxidase, Iridium, Amides, Enzyme Inhibitors. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactoperoxidase (LPO, EC 1.11.1.7), a heme metalloenzyme central to innate antimicrobial defence and implicated in mammary carcinogenesis, remains an underexplored target for metal‐based inhibitors. We evaluated six cyclometalated iridium(III) complexes bearing 2,2′‐bipyridine‐4,4′‐dicarboxamide ancillary ligands with varied N‐substituents as LPO inhibitors. Kinetic analysis using LPO purified from bovine milk revealed nanomolar inhibition (IC 50 = 0.64–3.12 nM; Kᵢ = 0.05 ± 0.01–5.36 ± 1.88 nM), representing an approximately 10 7 ‐fold potency advantage over the benchmark sulfonamide acetazolamide. Lineweaver–Burk analysis showed substituent‐dependent inhibition: complexes 1, 2, and 4 were competitive, whereas 3, 5, and 6 were non‐competitive, indicating that peripheral steric features influence the inhibition mechanism. Density functional theory calculations showed smaller HOMO–LUMO gaps and higher electrophilicity indices than acetazolamide, although no single descriptor predicted activity within the series. Molecular docking supported binding within the distal heme cavity, with representative interactions including π–π stacking and hydrogen bonding involving Gln‐105 and His‐109. All complexes reduced MDA‐MB‐231 cell viability; among those with reliably determined IC 50 values, complex 4 showed the greatest cytotoxicity (IC 50 = 18.28 µM). These findings identify amide‐linked Ir(III) complexes as highly potent LPO inhibitors with substituent‐dependent inhibition modes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoperoxidaseIridiumAmidesEnzyme InhibitorsAntineoplastic AgentsCoordination ComplexesAnimalsStructure-Activity RelationshipHumansMolecular Docking SimulationCattleMolecular StructureCell Line, TumorFemaleDose-Response Relationship, DrugMilkKineticsInhibitory Concentration 50

Stichwörter der Autor:innen

inhibition mechanismiridium(III) complexeslactoperoxidasemolecular dockingtriple‐negative breast cancer

Substanzen

LactoperoxidaseIridiumAmidesEnzyme InhibitorsAntineoplastic AgentsCoordination Complexes

Autor:innen und Institutionen

  • Faculty of Engineering, Department of Bioengineering, Bilecik Seyh Edebali University, Bilecik, Türkiye.
  • Science and Advanced Technologies Research Center (BILTAM), Istanbul Medeniyet University, Istanbul, Türkiye.
  • Department of Molecular Biology and Genetics, Istanbul Medeniyet University, Istanbul, Türkiye.
  • Department of Chemistry, Istanbul Medeniyet University, Istanbul, Türkiye.
  • Department of Engineering Basic Sciences, Istanbul Medeniyet University, Istanbul, Türkiye.

ORCID-Profile: Kevser Kübra Kırboğa, Fatma Sağır, Zeynep Köksal

Zitieren

APA

Kırboğa, K. K., Sağır, F., Köksal, Z., & Şahin, Ç. (2026). Steric Control of Competitive Versus Noncompetitive Lactoperoxidase Inhibition by Amide‐Linked Iridium(III) Complexes. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70346

Vancouver

Kırboğa KK, Sağır F, Köksal Z, Şahin Ç. Steric Control of Competitive Versus Noncompetitive Lactoperoxidase Inhibition by Amide‐Linked Iridium(III) Complexes. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70346

BibTeX
@article{Krboa2026,
  author = {Kırboğa, Kevser Kübra and Sağır, Fatma and Köksal, Zeynep and Şahin, Çiğdem},
  title = {Steric Control of Competitive Versus Noncompetitive Lactoperoxidase Inhibition by Amide‐Linked Iridium(III) Complexes},
  journal = {Archiv der Pharmazie},
  year = {2026},
  doi = {10.1002/ardp.70346}
}
Kostenlos starten →